Panagora Asset Management’s Tempest Therapeutics TPST Stock Holding History
Bought
Maintained
Sold
Other funds holding TPST
NMC
GPP
B
AIC
BCM
Panagora Asset Management's TPST Position: Q2 2020 in Review
Panagora Asset Management sold out of Tempest Therapeutics (TPST) in Q2 2020, closing a stake of 77 shares — an estimated $80K sold.
Panagora Asset Management first reported a position in TPST in Q2 2013 and held it in 14 quarters. The position peaked at $731K in Q4 2014. 51 funds tracked by Wall St. Rank hold TPST as of Q2 2020.
- Panagora Asset Management reported no remaining Tempest Therapeutics position as of Q2 2020 after selling out during the quarter.
- Panagora Asset Management sold 77 Tempest Therapeutics shares in Q2 2020, an estimated $80K.
- Panagora Asset Management first reported a position in Tempest Therapeutics in Q2 2013 and held it in 14 quarters.
- Panagora Asset Management's Tempest Therapeutics position peaked at $731K in Q4 2014.
- 51 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2020.
Based on Panagora Asset Management's 13F filing for Q2 2020, filed 12 Aug 2020.